GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
52.21
-4.06 (-7.22%)
At close: Jun 5, 2026, 4:00 PM EDT
52.50
+0.29 (0.56%)
After-hours: Jun 5, 2026, 5:14 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $1.55 billion as of June 5, 2026. Its market cap has decreased by -24.67% in one year.
Market Cap
1.55B
Enterprise Value
1.55B
1-Year Change
-24.67%
Ranking
Category
Stock Price
$52.21
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $1.55B, a decrease of -91.34%. That is a compound annual growth rate of -35.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 1.67B | -55.56% |
| Dec 31, 2025 | 3.76B | 78.04% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 4.60B |
| Sotera Health Company | 4.44B |
| RadNet | 4.15B |
| Veracyte | 3.98B |
| Adaptive Biotechnologies | 2.89B |
| GRAIL | 2.86B |
| NeoGenomics | 1.47B |
| Personalis | 1.27B |